ATRA vs VRTX: Which Stock is Better?
Side-by-side comparison of Atara Biotherapeutics Inc and Vertex Pharmaceuticals Inc in 2026
ATRA
Atara Biotherapeutics Inc
$5.12
VRTX
Vertex Pharmaceuticals Inc
$456.69
Key Metrics Comparison
| Metric | ATRA | VRTX | Winner |
|---|---|---|---|
| Market Cap | $37.28M | $116.00B | VRTX |
| P/E Ratio | 1.77 | 30.12 | ATRA |
| EPS (TTM) | $2.92 | $15.16 | VRTX |
| Revenue Growth | -0.9% | 0.1% | VRTX |
| Gross Margin | 46.8% | 53.7% | VRTX |
Analyze ATRA
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ATRA or VRTX a better investment?
Comparing ATRA and VRTX: Atara Biotherapeutics Inc has a market cap of $37.28M while Vertex Pharmaceuticals Inc has $116.00B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ATRA and VRTX?
ATRA (Atara Biotherapeutics Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ATRA or VRTX?
Based on P/E ratios, ATRA trades at a lower multiple (1.8x vs 30.1x).
Which is growing faster: ATRA or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.9% for ATRA.
Which company is more profitable: ATRA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 46.8% for ATRA.
Which is the larger company: ATRA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $116.00B compared to $37.28M for ATRA.
Should I buy ATRA or VRTX in 2026?
Both ATRA and VRTX have investment merit. ATRA trades at $5.12 while VRTX trades at $456.69. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ATRA and VRTX stock?
Key differences: Market Cap ($37.28M vs $116.00B), P/E Ratio (1.8x vs 30.1x), Revenue Growth (-0.9% vs 0.1%), Gross Margin (46.8% vs 53.7%).